Ocular Motor Dysfunction in Ocular Myasthenia Gravis: Effects of Treatment

Update Item Information
Identifier 20050214_nanos_sciplatform_04.pdf
Title Ocular Motor Dysfunction in Ocular Myasthenia Gravis: Effects of Treatment
Creator Mark J. Kupersmith; Gui-shuang Ying
Affiliation (MJK) New York, NY; (GSY) Philadelphia, PA
Subject Ocular Myasthenia Gravis; Prednisone; Pyridostigmine
Description The optimal treatment of the ophthalmoparesis associated with ocular myasthenia gravis (OMG) remains unknown. We evaluated the efficacy of prednisone and pyridostigmine in reducing diplopia and ocular motor dysfunction in patients with OMG.
Date 2005-02-14
Language eng
Format application/pdf
Type Text
Source 2005 North American Neuro-Ophthalmology Society Annual Meeting
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6wt20pk
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 181183
Reference URL https://collections.lib.utah.edu/ark:/87278/s6wt20pk
Back to Search Results